These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15118507)

  • 1. Update on the ocular manifestations of systemic arterial hypertension.
    Luo BP; Brown GC
    Curr Opin Ophthalmol; 2004 Jun; 15(3):203-10. PubMed ID: 15118507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and the eye: applications of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
    Marshall EC; Malinovsky VE
    J Am Optom Assoc; 1998 May; 69(5):281-91. PubMed ID: 9610036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations of hypertension.
    Locke LC
    Optom Clin; 1992; 2(2):47-76. PubMed ID: 1504479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension-related eye disorders].
    Resch M; Süveges I; Németh J
    Orv Hetil; 2013 Nov; 154(45):1773-80. PubMed ID: 24184929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular signs of systemic hypertension: a review.
    Hurcomb PG; Wolffsohn JS; Napper GA
    Ophthalmic Physiol Opt; 2001 Nov; 21(6):430-40. PubMed ID: 11727871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the weapons are ready].
    Verdecchia P; Angeli F
    Rev Esp Cardiol; 2003 Sep; 56(9):843-7. PubMed ID: 14519269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.
    Hayreh SS
    Curr Opin Ophthalmol; 1999 Dec; 10(6):474-82. PubMed ID: 10662254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of JNC VI: new directions in the management of hypertension and cardiovascular risk.
    Sheps SG
    Am J Hypertens; 1999 Aug; 12(8 Pt 2):65S-72S. PubMed ID: 10478699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of arterial hypertension on the eye.
    Katsi V; Marketou M; Vlachopoulos C; Tousoulis D; Souretis G; Papageorgiou N; Stefanadis C; Vardas P; Kallikazaros I
    Curr Hypertens Rep; 2012 Dec; 14(6):581-90. PubMed ID: 22673879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and the eye: changing perspectives.
    Chatterjee S; Chattopadhyay S; Hope-Ross M; Lip PL
    J Hum Hypertens; 2002 Oct; 16(10):667-75. PubMed ID: 12420190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study.
    Lloyd-Jones DM; Evans JC; Larson MG; O'Donnell CJ; Wilson PW; Levy D
    Arch Intern Med; 1999 Oct; 159(18):2206-12. PubMed ID: 10527298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008)].
    Rosas M; Pastelín G; Vargas-Alarcón G; Martínez-Reding J; Lomelí C; Mendoza-González C; Lorenzo JA; Méndez A; Franco M; Sánchez-Lozada LG; Verdejo J; Sánchez N; Ruiz R; Férez-Santander SM; Attie F;
    Arch Cardiol Mex; 2008; 78 Suppl 2():S2-5-57. PubMed ID: 18928127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New staging system of the fifth Joint National Committee report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension.
    Pogue VA; Ellis C; Michel J; Francis CK
    Hypertension; 1996 Nov; 28(5):713-8. PubMed ID: 8901813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proportion of US adults potentially affected by the 2014 hypertension guideline.
    Navar-Boggan AM; Pencina MJ; Williams K; Sniderman AD; Peterson ED
    JAMA; 2014 Apr; 311(14):1424-9. PubMed ID: 24682242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
    Gaddam KK; Ventura H; Lavie CJ
    Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it time to treat prehypertension?
    Papadopoulos DP; Makris TK; Papademetriou V
    Hypertens Res; 2008 Sep; 31(9):1681-6. PubMed ID: 18971545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Padwal R; Larochelle P; Mahon JL; Lewanczuk RZ; McAlister FA; Rabkin SW; Hill MD; Feldman RD; Schiffrin EL; Campbell NR; Logan AG; Arnold M; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Leiter LA; Ogilvie RI; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Burns KD; Ruzicka M; deChamplain J; Pylypchuk G; Gledhill N; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Touyz RM; Tobe SW;
    Can J Cardiol; 2007 May; 23(7):539-50. PubMed ID: 17534460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cugini's syndrome: a new cardiovascular entity. Interview by G. M. Fara.
    Cugini P
    Ann Ig; 2009; 21(3):189-95. PubMed ID: 19798897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of ocular lesions associated with hypertension in a population of geriatric cats in Auckland, New Zealand.
    Carter JM; Irving AC; Bridges JP; Jones BR
    N Z Vet J; 2014 Jan; 62(1):21-9. PubMed ID: 24138677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension: Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure guidelines.
    Lackland DT
    Curr Opin Neurol; 2013 Feb; 26(1):8-12. PubMed ID: 23241566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.